Clinical trial of concurrent chemoradiotherapy with Docetaxel, Cisplatin and 5-Fluorouracil (TPF) in patients with locally advanced head and neck squamous cell carcinoma
Not Applicable
Recruiting
- Conditions
- ocally advanced head and neck squamous cell carcinoma
- Registration Number
- JPRN-UMIN000021841
- Lead Sponsor
- Yokohama City University hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1. History of the serious hypersensitivity for drugs used in this trial 2. The needs to use phenytoin or warfarin potassium during this trial. 3. 24-h creatinine clearance <65 ml/min 4. Active infection 5. Active digestive tract disorder 6. Evidence of interstinal lung disease, or pulmonary fibrosis 7. Evidence of uncontrolled diabetes mellitus 8. Evidence of uncontrolled cardiovascular disease 9. Severe hepatic dysfunction 10. Severe watery diarrhea 11. Lactating, pregnant or possibly pregnant women, or those willing to become pregnant 12. Physician concludes that the patient's participation in this trial is inappropriate
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ocoregional free survival
- Secondary Outcome Measures
Name Time Method